Areas of Concern When Combining, Sequencing Liver-directed Therapy With Systemic Therapy for Gastrointestinal NETs

Pharmacy Times interviewed Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors (NETs) Medical Virtual Symposium discussing sequencing and combination of liver-directed therapy (LDT) with systemic therapies.

During the interview, Gabriel discussed areas of concern when approaching the combination and sequencing of LDT with systemic therapy when treating patients with gastrointestinal NETs.